MEP10009A - 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-hpyrrole derivatives as acid secretion inhibitors - Google Patents

1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-hpyrrole derivatives as acid secretion inhibitors

Info

Publication number
MEP10009A
MEP10009A MEP-100/09A MEP10009A MEP10009A ME P10009 A MEP10009 A ME P10009A ME P10009 A MEP10009 A ME P10009A ME P10009 A MEP10009 A ME P10009A
Authority
ME
Montenegro
Prior art keywords
group
optionally substituted
acid secretion
hpyrrole
heterocyclylsulfonyl
Prior art date
Application number
MEP-100/09A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Masahiro Kajino
Atsushi Hasuoka
Haruyuki Nishida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37517870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP10009(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of MEP10009A publication Critical patent/MEP10009A/xx
Publication of ME00610B publication Critical patent/ME00610B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
MEP-2009-100A 2005-08-30 2006-08-29 1 –heterociklilsulfonil, 2 –aminometil, 5– (hetero–) aril supstituisan 1–h–pirol derivati kao inhibitori lučenja kiseline ME00610B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005250356 2005-08-30
JP2006100626 2006-03-31
PCT/JP2006/317408 WO2007026916A1 (en) 2005-08-30 2006-08-29 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors

Publications (2)

Publication Number Publication Date
MEP10009A true MEP10009A (en) 2011-12-20
ME00610B ME00610B (me) 2011-12-20

Family

ID=37517870

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2009-100A ME00610B (me) 2005-08-30 2006-08-29 1 –heterociklilsulfonil, 2 –aminometil, 5– (hetero–) aril supstituisan 1–h–pirol derivati kao inhibitori lučenja kiseline

Country Status (32)

Country Link
US (7) US7977488B2 (sr)
EP (2) EP1919865B1 (sr)
JP (3) JP4035559B1 (sr)
KR (2) KR101115857B1 (sr)
CN (1) CN101300229B (sr)
AR (1) AR055144A1 (sr)
AT (1) ATE504567T1 (sr)
AU (1) AU2006285641A1 (sr)
BR (2) BR122017028096B8 (sr)
CA (1) CA2621182C (sr)
CR (1) CR9755A (sr)
CY (2) CY1111922T1 (sr)
DE (1) DE602006021195D1 (sr)
DK (2) DK1919865T3 (sr)
ES (2) ES2364498T3 (sr)
GE (1) GEP20105044B (sr)
HR (2) HRP20110473T1 (sr)
IL (1) IL189375A (sr)
JO (1) JO2791B1 (sr)
MA (1) MA29773B1 (sr)
ME (1) ME00610B (sr)
NO (1) NO341894B1 (sr)
NZ (1) NZ566378A (sr)
PE (2) PE20110009A1 (sr)
PL (2) PL1919865T3 (sr)
PT (2) PT2327692E (sr)
RS (2) RS52473B9 (sr)
SI (2) SI2327692T1 (sr)
TW (1) TWI358296B (sr)
UA (1) UA94424C2 (sr)
WO (1) WO2007026916A1 (sr)
ZA (1) ZA200802488B (sr)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20105044B (en) * 2005-08-30 2010-07-12 Takeda Pharmaceuticals Co 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
WO2009041447A1 (ja) 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited ５員複素環化合物
AR068538A1 (es) * 2007-09-28 2009-11-18 Takeda Pharmaceutical Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido
US8309580B2 (en) 2007-11-01 2012-11-13 Takeda Pharmaceutical Company Limited Heterocyclic compound
UY32008A (es) * 2008-07-28 2010-02-26 Takeda Pharmaceutical Composición farmacéutica
WO2010021149A1 (ja) * 2008-08-21 2010-02-25 武田薬品工業株式会社 酸分泌抑制スピロ化合物
US8592597B2 (en) * 2008-08-27 2013-11-26 Takeda Pharmaceutical Company Limited Pyrrole compounds
EP3613734B1 (en) 2009-02-25 2021-08-25 Takeda Pharmaceutical Company Limited Process for producing pyrrole compound
EP2412713B1 (en) 2009-03-26 2016-11-30 Takeda Pharmaceutical Company Limited Pyrazole compound
KR101605063B1 (ko) 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
WO2012095691A1 (en) * 2011-01-15 2012-07-19 Jubilant Life Sciences Ltd. An improved process for producing aminopyridines
CN102863371B (zh) * 2011-07-06 2016-04-13 中国科学院上海有机化学研究所 氟代二氢吡咯或氟代吡咯
CA2877619C (en) 2012-06-27 2020-09-22 Takeda Pharmaceutical Company Limited Liquid preparations of amines and organic acids stabilized by salts
WO2014019442A1 (zh) * 2012-08-03 2014-02-06 上海恒瑞医药有限公司 苯并呋喃类衍生物、其制备方法及其在医药上的应用
CA2891523A1 (en) 2012-11-19 2014-05-22 Jiangsu Hansoh Pharmaceutical Co., Ltd. Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
CA2902624C (en) 2013-02-28 2021-05-18 Takeda Pharmaceutical Company Limited Method for producing sulfonyl chloride compound
KR102084185B1 (ko) 2013-08-29 2020-03-04 주식회사 대웅제약 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
KR102129842B1 (ko) 2013-10-02 2020-07-06 주식회사 대웅제약 술포닐인돌 유도체 및 이의 제조방법
CN103951652B (zh) * 2014-04-18 2015-09-23 潍坊博创国际生物医药研究院 5-(2-氟苯基)-n-甲基-1-(3-吡啶基磺酰基)-1h-吡咯-3-甲胺水溶性有机酸盐和注射剂及它们的制备方法
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用
CN105646451A (zh) * 2014-11-12 2016-06-08 江苏豪森药业集团有限公司 钾离子竞争性酸阻滞剂的晶型及其制备方法
CN107001262A (zh) * 2014-11-19 2017-08-01 江苏豪森药业集团有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其晶型、中间体和医药用途
CN104447490B (zh) * 2014-11-19 2017-06-06 连云港恒运医药有限公司 一种质子泵抑制剂的晶型、制备中间体及其合成方法和医药用途
CN104447491B (zh) * 2014-11-19 2017-06-23 连云港恒运医药有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途
CN105693693A (zh) * 2014-11-27 2016-06-22 江苏柯菲平医药股份有限公司 一种吡咯类胃酸分泌和抑制剂化合物盐的制备
CN104356043B (zh) * 2014-11-27 2016-10-26 重庆威尔德浩瑞医药化工有限公司 一种制备5-(2-氟苯基)-1h-吡咯-3-甲醛的方法
CN105708812A (zh) * 2014-12-02 2016-06-29 江苏柯菲平医药股份有限公司 一种5-（2-氟苯基）-n-甲基-1-（3-吡啶基磺酰基）-1h-吡咯-3-甲氨冻干粉针及其制备方法
CN104860923B (zh) * 2015-01-21 2018-01-12 山东康美乐医药科技有限公司 富马酸沃诺拉赞的制备方法
CN105985278A (zh) * 2015-01-27 2016-10-05 江苏柯菲平医药股份有限公司 吡咯磺酰类衍生物、其制备方法及其在医药上的应用
CN105982867A (zh) * 2015-02-27 2016-10-05 江苏柯菲平医药股份有限公司 一种h009冻干粉针及其制备方法
CN106031710B (zh) * 2015-03-16 2019-03-12 南京优科制药有限公司 一种富马酸氟呐普拉赞的注射剂及其制备方法
CN104814964B (zh) * 2015-04-16 2018-07-31 广东赛烽医药科技有限公司 一种抗胃幽门螺旋杆菌的药物组合物、制备方法及其应用
KR101613245B1 (ko) * 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
CN105315258A (zh) * 2015-05-16 2016-02-10 南京海纳医药科技有限公司 富马酸沃诺拉赞多晶型及其制备方法
CN104860926B (zh) * 2015-06-10 2017-06-30 浙江诚意药业股份有限公司 一种富马酸沃诺拉赞的制备方法
CN104945313A (zh) * 2015-06-19 2015-09-30 洪帅金 一种2-甲基-3-溴吡啶的制备方法
CN104926790B (zh) * 2015-06-29 2017-07-07 江苏奥赛康药业股份有限公司 一种高纯度Vonoprazan Fumarate化合物及其中间体、杂质以及它们的制备方法
CA2991115C (en) 2015-06-30 2024-06-25 Takeda Pharmaceutical Company Limited Method for producing pyrrole compound
CN104974082A (zh) * 2015-07-26 2015-10-14 陈吉美 一种2-甲基-4-溴吡啶的制备方法
CN106432191A (zh) * 2015-08-10 2017-02-22 陕西合成药业股份有限公司 一种新的吡咯类衍生物、其制备方法及其在医药上的应用
CN105106203B (zh) * 2015-08-17 2019-04-05 江苏豪森药业集团有限公司 富马酸沃诺拉赞的药物组合物及其制备方法
CN105085484B (zh) * 2015-08-21 2017-11-24 南京济群医药科技股份有限公司 一种富马酸沃诺拉赞的制备方法
CN105030720B (zh) * 2015-08-26 2019-12-10 迪沙药业集团有限公司 一种富马酸沃诺拉赞肠溶片及其制备方法
CN105030725B (zh) * 2015-08-26 2019-12-10 迪沙药业集团有限公司 一种富马酸沃诺拉赞肠溶组合物及其制备方法
CN106478597A (zh) * 2015-09-02 2017-03-08 中美华世通生物医药科技（武汉）有限公司 富马酸沃诺拉赞单晶及其制备方法和用途
CN106511344A (zh) * 2015-09-14 2017-03-22 王虹 一种胃酸分泌抑制剂的新用途
CN106632246A (zh) * 2015-10-30 2017-05-10 江苏柯菲平医药股份有限公司 一种吡咯类胃酸分泌抑制剂化合物盐的晶型及其制备
CN105198802A (zh) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 一种2-甲基-3-溴吡啶的制备方法
CN105294653B (zh) * 2015-11-16 2017-08-15 山东罗欣药业集团股份有限公司 富马酸沃诺拉赞的制备工艺
CN105440019A (zh) * 2015-12-17 2016-03-30 昆明贵研药业有限公司 一种治疗胃酸疾病药物的制备方法
CN105503828A (zh) * 2015-12-24 2016-04-20 北京康立生医药技术开发有限公司 一种吡咯衍生物的富马酸盐的制备方法
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR20170113040A (ko) * 2016-03-25 2017-10-12 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염
CN106074406A (zh) * 2016-06-12 2016-11-09 佛山市腾瑞医药科技有限公司 一种富马酸沃诺拉赞分散片及其制备方法
CN108191829B (zh) * 2016-06-30 2020-07-03 珠海赛隆药业股份有限公司（长沙）医药研发中心 应用富马酸沃诺拉赞中间体ⅳ制备富马酸沃诺拉赞的方法
KR101777971B1 (ko) 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
CN106187852B (zh) * 2016-07-07 2019-01-15 江西同和药业股份有限公司 一种富马酸沃诺拉赞中间体的制备方法
CN106431871A (zh) * 2016-08-17 2017-02-22 济南贝莱尔化学科技有限公司 一种2′‑溴代邻氟苯乙酮的制备方法
CN106243008B (zh) * 2016-08-22 2018-09-04 山东金城生物药业有限公司 富马酸沃诺拉赞中间体5-(2-氟苯基)-1h-吡咯-3-甲醛的制备方法
CN107778207A (zh) * 2016-08-25 2018-03-09 广东东阳光药业有限公司 富马酸沃诺拉赞中间体及其制备方法和用途
CN106397404A (zh) * 2016-08-31 2017-02-15 山东新华制药股份有限公司 5‑（2‑氟苯基）‑1‑（吡啶‑3‑基磺酰基）‑1h‑吡咯‑3‑甲醛的制备方法
CN106380464A (zh) * 2016-08-31 2017-02-08 山东新华制药股份有限公司 氟呐普拉赞关键中间体的制备方法
CN107814758B (zh) * 2016-09-12 2022-10-11 江苏柯菲平医药股份有限公司 一种吡咯磺酸类化合物盐型制备
CN107879964B (zh) * 2016-09-29 2023-02-10 江苏柯菲平医药股份有限公司 1-(5-(2-氟苯基)-1-(3-(3-甲氧丙氧基)苯磺酰氯)-1h-吡咯-3-基)-n-甲基胺的制备方法
CN108069891B (zh) * 2016-11-16 2022-09-20 江苏柯菲平医药股份有限公司 一类甲基甲胺盐酸盐的a晶型、制备及其应用
CN106892900A (zh) * 2017-04-10 2017-06-27 山东裕欣药业有限公司 一种富马酸沃诺拉赞及其制备方法
CN106905216A (zh) * 2017-04-19 2017-06-30 刘德鹏 一种质子泵抑制剂药物化合物及其制备方法
CN107011327A (zh) * 2017-04-19 2017-08-04 刘德鹏 一种治疗消化性溃疡的药物化合物及其制备方法
CN108794449B (zh) * 2017-05-05 2023-08-04 广东东阳光药业有限公司 一种氘代富马酸沃诺拉赞代谢物的合成方法
KR102233455B1 (ko) 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
ES2921931T3 (es) * 2017-07-10 2022-09-02 Takeda Pharmaceuticals Co Preparación que comprende vonoprazán
KR20190057569A (ko) 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
JP7227925B2 (ja) * 2017-12-27 2023-02-22 日本ケミファ株式会社 １－［５－（２－フルオロフェニル）－１－（ピリジン－３－イルスルホニル）－１ｈ－ピロ－ル－３－イル］－ｎ－メチルメタンアミンモノフマル酸塩の製造法
CN108558831B (zh) * 2018-06-08 2021-07-27 上海璃道医药科技有限公司 取代吡咯-4-烷基胺类化合物及其用途
CN109053684A (zh) * 2018-08-09 2018-12-21 珠海润都制药股份有限公司 一种富马酸沃诺拉赞及其中间体的制备方法
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN110272409A (zh) * 2019-03-11 2019-09-24 南京百迪尔生物医药有限公司 一步法合成沃诺拉赞的新方法
KR102222443B1 (ko) 2019-04-11 2021-03-03 일동제약(주) 1-[5-(2-플루오로페닐)-1-(피리딘-3-일술포닐)-1h-피롤-3-일]-n-메틸메탄아민의 신규염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
CN112300123B (zh) * 2019-08-02 2023-07-18 上海天慈国际药业有限公司 一种沃诺拉赞中间体的制备方法
CN116987063A (zh) * 2019-09-23 2023-11-03 吉林汇康制药有限公司 一种低杂质富马酸沃诺拉赞的制备方法
CN110627628A (zh) * 2019-09-24 2019-12-31 上海应用技术大学 一种β-碘代二氟丙酮类衍生物及其制备方法
WO2021104256A1 (zh) * 2019-11-25 2021-06-03 杭州华东医药集团新药研究院有限公司 一种杂环衍生物、其药物组合物及用途
CN111018835B (zh) * 2019-12-16 2022-09-20 株洲千金药业股份有限公司 一种沃诺拉赞的纯化方法
CN113527536B (zh) * 2020-04-21 2024-03-22 杭州德柯医疗科技有限公司 一种含氟多糖高分子化合物及其制备方法
CN114349737B (zh) * 2020-04-26 2023-06-09 南京烁慧医药科技有限公司 一种含磺酰胺结构的化合物及其应用、一种药物组合物及其应用
CN111484458B (zh) * 2020-05-25 2022-12-27 南京竹园医药科技有限公司 一种2-羟基-5-磺酸基嘧啶的制备方法
ES3014815T3 (en) * 2020-06-17 2025-04-25 Ildong Pharmaceutical Co Ltd Novel acid secretion inhibitor and use thereof
CN111943932B (zh) * 2020-08-06 2023-07-14 四川国康药业有限公司 一种可以治疗消化性溃疡的3-吡啶磺酰-1-n-杂吡咯衍生物及其制备方法和用途
CN114149411B (zh) * 2020-09-08 2025-05-16 鲁南制药集团股份有限公司 一种沃诺拉赞中间体及其制备方法与应用
CN112812099B (zh) * 2021-01-19 2022-04-26 珠海赛隆药业股份有限公司 一种用于治疗消化性溃疡的化合物及其制法和用途
CN114989138B (zh) * 2021-03-02 2023-06-13 天地恒一制药股份有限公司 沃诺拉赞盐及其晶型、制备方法和用途
CN115594622B (zh) * 2021-07-09 2025-03-21 天地恒一制药股份有限公司 一种吡咯磺酰类衍生物、及其制备方法与应用
CN116239606B (zh) * 2021-07-09 2025-09-02 天地恒一制药股份有限公司 一种吡咯磺酰类衍生物、及其制备方法与应用
CN113620930B (zh) * 2021-07-12 2022-08-16 南京烁慧医药科技有限公司 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用
CN114105962B (zh) * 2021-10-26 2024-11-05 南京烁慧医药科技有限公司 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用
CN118401510A (zh) * 2021-12-15 2024-07-26 日东制药株式会社 1-磺酰基吡咯衍生物的新颖盐类、其制备方法及包含其的药物组合物
KR20230102353A (ko) * 2021-12-30 2023-07-07 주식회사 대웅제약 삼중음성유방암의 예방 또는 치료용 약학적 조성물
KR102749187B1 (ko) 2022-01-24 2025-01-03 순천향대학교 산학협력단 칼륨 경쟁적 위산분비 억제제의 신규한 공결정, 이의 제조방법 및 이를 포함하는 약제학적 조성물
CN115232107A (zh) * 2022-07-29 2022-10-25 南京唯创远医药科技有限公司 一种高纯度富马酸伏诺拉生的制备方法
US12060148B2 (en) 2022-08-16 2024-08-13 Honeywell International Inc. Ground resonance detection and warning system and method
CN116023364A (zh) * 2023-01-31 2023-04-28 山东铂源药业股份有限公司 一种富马酸沃诺拉赞的制备方法
KR20250014615A (ko) * 2023-07-21 2025-02-03 한림제약(주) 보노프라잔 푸마르산염의 제조방법
CN117050009A (zh) * 2023-08-17 2023-11-14 台州臻挚生物科技有限公司 一种4-三氟甲基吡啶中间体核心母核及其衍生物的制备方法
KR20250095434A (ko) 2023-12-19 2025-06-26 주식회사 경보제약 보노프라잔 토실레이트 염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
CN117462507B (zh) * 2023-12-28 2024-03-15 山东齐都药业有限公司 富马酸伏诺拉生药物组合物及其制备方法
CN118108705A (zh) * 2024-01-29 2024-05-31 浙江工业大学 一种富马酸沃诺拉赞的制备方法
WO2025181220A1 (en) 2024-02-29 2025-09-04 Dipharma Francis S.R.L. Process of purifying a drug used in the treatment of acid-related disorders

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3772301D1 (de) 1986-08-29 1991-09-26 Pfizer 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren.
US5128366A (en) 1990-07-05 1992-07-07 Shinogi & Co., Ltd. Pyrrole derivatives
WO1992004025A1 (en) 1990-08-31 1992-03-19 Warner-Lambert Company Amino acid analogs as cck antagonists
WO1993007751A1 (en) 1991-10-18 1993-04-29 Monsanto Company Fungicides for the control of take-all disease of plants
MX9205392A (es) 1991-10-29 1993-04-01 Du Pont Triazolcarbozamidas herbicidas y procedimiento para su obtencion.
JPH06135961A (ja) 1992-10-23 1994-05-17 Nippon Iyakuhin Kogyo Kk 新規ジフェニルピロリルフラン誘導体
US5286742A (en) * 1992-11-03 1994-02-15 American Cyanamid Company Pyrrole thiocarboxamide insecticidal and acaricidal agents
US5480902A (en) * 1993-08-31 1996-01-02 American Cyanamid Company Thienylpyrrole fungicidal agents
JPH08119936A (ja) 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
JPH0930967A (ja) 1995-07-17 1997-02-04 Chugai Pharmaceut Co Ltd 抗潰瘍剤
DE69716449T2 (de) 1996-08-28 2003-08-07 The Procter & Gamble Company, Cincinnati Substituierte zyklische amine als metalloproteaseinhibitoren
ES2331860T3 (es) 1996-12-23 2010-01-18 Bristol-Myers Squibb Pharma Company Compuestos heteroaromaticos que contienen nitrogeno como inhibidores del factor xa.
JPH11209344A (ja) 1998-01-26 1999-08-03 Kyowa Hakko Kogyo Co Ltd 含窒素複素環化合物
GB9817548D0 (en) * 1998-08-12 1998-10-07 Novartis Ag Organic compounds
EP1176139B1 (en) 1999-03-10 2005-05-18 Shionogi & Co., Ltd. Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
TW575561B (en) 1999-03-25 2004-02-11 Hoffmann La Roche 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
DE19913483A1 (de) 1999-03-25 2000-09-28 Goedecke Ag Verfahren zur Herstellung von Heterocyclischen Carbamaten aus Aza-Heterocyclen und Kohlendioxid
AU3783100A (en) 1999-06-14 2000-12-21 Dow Agrosciences Llc Substituted triazoles, imidazoles and pyrazoles as herbicides
ATE309995T1 (de) * 1999-08-26 2005-12-15 Aventis Pharma Inc Substituierte (aminoiminomethyl oder aminomethyl) dihydrobenzofurane und benozopyrane
EP1284260A4 (en) 2000-05-22 2004-03-31 Takeda Chemical Industries Ltd TYROSIN PHOSPHATASE INHIBITORS
US6589978B2 (en) 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
GB0016453D0 (en) 2000-07-04 2000-08-23 Hoffmann La Roche Pyrrole derivatives
US7544690B2 (en) 2001-10-01 2009-06-09 Taisho Pharmaceutical Co., Ltd. MCH receptor antagonists
WO2003040147A1 (en) 2001-11-08 2003-05-15 Pharmacia & Upjohn Company Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
EP1451179A1 (en) 2001-11-22 2004-09-01 Ciba SC Holding AG Pyrrole synthesis
EP1466902A4 (en) 2001-12-28 2005-11-09 Takeda Pharmaceutical ANTAGONISTS OF THE ANDROGEN RECEPTOR
WO2003068738A1 (en) 2002-02-11 2003-08-21 Neurocrine Biosciences, Inc. Pyrrole derivatives as ligands of melanocortin receptors
AU2003209114A1 (en) 2002-02-14 2003-09-04 Wyeth Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
TW200306191A (en) 2002-02-22 2003-11-16 Teijin Ltd Pyrrolopyrimidine derivatives
NZ536444A (en) * 2002-05-17 2006-12-22 Merckle Gmbh Annelated pyrrole compounds as gastric proton pump inhibitors for treating ulcer
AU2003245464A1 (en) 2002-06-13 2003-12-31 E.I. Du Pont De Nemours And Company Pyrazole and pyrrole carboxamide insecticides
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
BR0313396A (pt) 2002-08-12 2005-06-28 Sugen Inc 3-pirrolil-piridopirazóis e 3-pirrolil-indazóis, como inibidores de quinase
JP2004315511A (ja) 2003-03-31 2004-11-11 Taisho Pharmaceut Co Ltd Ｍｃｈ受容体アンタゴニスト
WO2004103968A1 (en) 2003-05-26 2004-12-02 Aponetics Ag Sulfopyrroles
JP2005044740A (ja) 2003-07-25 2005-02-17 Taniguchi Heaters Kk 空焚きセンサー内蔵の液中用ヒーター
JP4239860B2 (ja) 2004-03-08 2009-03-18 ヤマハ株式会社 擦弦楽器用駒および擦弦楽器
EP1769092A4 (en) 2004-06-29 2008-08-06 Europ Nickel Plc IMPROVED LIXIVIATION OF BASE METALS
WO2006036024A1 (ja) * 2004-09-30 2006-04-06 Takeda Pharmaceutical Company Limited プロトンポンプ阻害薬
JP2006100626A (ja) 2004-09-30 2006-04-13 Fuji Photo Film Co Ltd 半導体発光装置
EP1655284A1 (en) 2004-10-26 2006-05-10 Aponetics AG 2-Phenylsulfopyrroles
GEP20105044B (en) * 2005-08-30 2010-07-12 Takeda Pharmaceuticals Co 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
KR101366856B1 (ko) * 2007-03-29 2014-02-21 삼성전자주식회사 다양한 포트를 통해 입력되는 영상을 디스플레이하는디스플레이 장치

Also Published As

Publication number Publication date
RU2415838C2 (ru) 2011-04-10
US20110301173A1 (en) 2011-12-08
IL189375A0 (en) 2008-06-05
US20120088797A1 (en) 2012-04-12
BR122017028096B1 (pt) 2021-04-13
ES2364498T3 (es) 2011-09-05
HK1118547A1 (en) 2009-02-13
DE602006021195D1 (en) 2011-05-19
CA2621182C (en) 2014-03-18
CN101300229A (zh) 2008-11-05
PE20110009A1 (es) 2011-01-31
WO2007026916A1 (en) 2007-03-08
US7498337B2 (en) 2009-03-03
JP5204426B2 (ja) 2013-06-05
CA2621182A1 (en) 2007-03-08
DK2327692T3 (da) 2012-10-15
US8338461B2 (en) 2012-12-25
HRP20120792T1 (hr) 2012-10-31
US20110301174A1 (en) 2011-12-08
DK2327692T5 (da) 2014-06-23
SI2327692T1 (sl) 2012-11-30
BRPI0615111A2 (pt) 2011-05-03
KR20110091826A (ko) 2011-08-12
TW200800185A (en) 2008-01-01
IL189375A (en) 2013-05-30
JP5687293B2 (ja) 2015-03-18
UA94424C2 (en) 2011-05-10
EP2327692B1 (en) 2012-07-18
JP2008056659A (ja) 2008-03-13
US8436187B2 (en) 2013-05-07
AR055144A1 (es) 2007-08-08
JP2008522952A (ja) 2008-07-03
SI1919865T1 (sl) 2011-07-29
EP2327692B9 (en) 2014-06-04
CR9755A (es) 2013-06-14
ES2391757T3 (es) 2012-11-29
US20090275591A1 (en) 2009-11-05
EP1919865B1 (en) 2011-04-06
US7977488B2 (en) 2011-07-12
ATE504567T1 (de) 2011-04-15
PL2327692T3 (pl) 2012-12-31
KR20080039998A (ko) 2008-05-07
AU2006285641A1 (en) 2007-03-08
MA29773B1 (fr) 2008-09-01
HK1158627A1 (en) 2012-07-20
PL1919865T3 (pl) 2011-09-30
PT2327692E (pt) 2012-10-11
RU2008112153A (ru) 2009-10-10
US20110144161A1 (en) 2011-06-16
RS52473B (sr) 2013-02-28
NZ566378A (en) 2011-03-31
NO20081464L (no) 2008-05-23
BR122017028096B8 (pt) 2021-05-25
TWI358296B (en) 2012-02-21
JP4035559B1 (ja) 2008-01-23
ME00610B (me) 2011-12-20
GEP20105044B (en) 2010-07-12
CN101300229B (zh) 2011-10-05
BRPI0615111B8 (pt) 2021-05-25
RS52473B9 (sr) 2019-07-31
US20090143444A1 (en) 2009-06-04
BRPI0615111B1 (pt) 2020-02-18
RS51697B (sr) 2011-10-31
KR101115857B1 (ko) 2012-04-12
JO2791B1 (en) 2014-03-15
CY1114415T1 (el) 2016-12-14
NO341894B1 (no) 2018-02-12
EP1919865A1 (en) 2008-05-14
ZA200802488B (en) 2009-06-24
PE20070540A1 (es) 2007-06-26
KR101408561B1 (ko) 2014-06-19
CY1111922T1 (el) 2015-11-04
US8338462B2 (en) 2012-12-25
PT1919865E (pt) 2011-07-11
DK1919865T3 (da) 2011-05-23
US8299261B2 (en) 2012-10-30
JP2013100316A (ja) 2013-05-23
HRP20110473T1 (hr) 2011-07-31
US20070060623A1 (en) 2007-03-15
EP2327692A1 (en) 2011-06-01
US8415368B2 (en) 2013-04-09

Similar Documents

Publication Publication Date Title
MEP10009A (en) 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-hpyrrole derivatives as acid secretion inhibitors
MY165585A (en) Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
MEP8409A (en) Fused heterocyclic compound
WO2003080580A3 (en) Quinoline derivatives and their use as 5-ht6 ligands
AR105607A1 (es) Derivados heterocíclicos condensados sustituidos por 2-(het)arilo como pesticidas
WO2008108380A3 (en) Pyrrole compounds
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
MX344276B (es) Compuesto de piperidina novedoso o sal del mismo.
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
MY140070A (en) 4-(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
MX2016006685A (es) Compuestos heterociclicos de n-acilimino.
UA81561C2 (en) Use of n-arylhydrazine derivative and method for controlling non-crop pests
WO2008136444A1 (ja) 縮合複素環誘導体
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
AR056582A1 (es) COMPUESTOS DE PIRAZOLIL UREA CON ACTIVIDAD INHIBITORIA DE CINASA P38 Y FORMULACIoN FARMACÉUTICA QUE LO COMPRENDE
ATE491704T1 (de) 4-ä2-(cycloalkylamino)pyrimidin-4-ylü- (phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
WO2003080596A3 (en) Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
ATE308541T1 (de) 2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase
CA2422807A1 (en) N-substituted benzothiophenesulfonamide derivatives
MX2010010073A (es) Inhibidor de la metaloproteasa de matriz-2 y/o de la metaloproteasa de matriz-9.
AR057558A1 (es) Compuestos de cinolincarboxamida y composicion farmaceutica
ATE414692T1 (de) Pyridinketone mit herbizideffekt
AR074629A1 (es) Derivados de 1-bencil-cinolin-4-(1h)-ona sustituidos, su preparacion, composiciones farmaceuticas y su uso en el tratamiento de patologias asociadas con receptores de los cannabinoides cb2
MX2022013321A (es) Derivado de 2-heteroarilaminoquinazolinona.